‘The Question Is, What’s Going To Happen Next?’ – The Future For Biosimilars In Europe

With European biosimilars developers buoyed by recent regulatory moves, Medicines for Europe’s Isabell Remus and Julie Maréchal-Jamil discuss the next steps forward for the industry.